Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections

Conditions

• Complicated Intra-abdominal Infection

Interventions

• DRUG: CXA-101/ tazobactam and metronidazole
• DRUG: meropenem plus saline placebo

Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)